Literature DB >> 32819572

Cathepsin K is a potent disaggregase of α-synuclein fibrils.

Ryan P McGlinchey1, Shannon M Lacy1, Robert L Walker1, Jennifer C Lee2.   

Abstract

The intracellular accumulation of α-synuclein (α-syn) amyloid fibrils is a hallmark of Parkinson's disease. Because lysosomes are responsible for degrading aggregated species, enhancing lysosomal function could alleviate the overburden of α-syn. Previously, we showed that cysteine cathepsins (Cts) is the main class of lysosomal proteases that degrade α-syn, and in particular, CtsL was found to be capable of digesting α-syn fibrils. Here, we report that CtsK is a more potent protease for degrading α-syn amyloids. Using peptide mapping by liquid chromatography with mass spectrometry, critical cleavage sites involved in destabilizing fibril structure are identified. CtsK is only able to devour the internal regions after the removal of both N- and C-termini, indicating their protective role of the amyloid core from proteolytic attack. Our results suggest that if overexpressed in lysosomes, CtsK has the potential to ameliorate α-syn pathology. Published by Elsevier Inc.

Entities:  

Keywords:  Cysteine cathepsin; LC-MS; Parkinson’s disease; α-synuclein

Year:  2020        PMID: 32819572      PMCID: PMC7478362          DOI: 10.1016/j.bbrc.2020.06.155

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.

Authors:  Zachary A Sorrentino; Niran Vijayaraghavan; Kimberly-Marie Gorion; Cara J Riffe; Kevin H Strang; Jason Caldwell; Benoit I Giasson
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

Review 2.  The Future of Cysteine Cathepsins in Disease Management.

Authors:  Lovro Kramer; Dušan Turk; Boris Turk
Journal:  Trends Pharmacol Sci       Date:  2017-06-28       Impact factor: 14.819

3.  Structural Insights into α-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease-Related C-Terminal Truncations.

Authors:  Xiaodan Ni; Ryan P McGlinchey; Jiansen Jiang; Jennifer C Lee
Journal:  J Mol Biol       Date:  2019-07-08       Impact factor: 5.469

4.  alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

Authors:  M G Spillantini; R A Crowther; R Jakes; M Hasegawa; M Goedert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 5.  Lysosomal storage disorders - challenges, concepts and avenues for therapy: beyond rare diseases.

Authors:  André R A Marques; Paul Saftig
Journal:  J Cell Sci       Date:  2019-01-16       Impact factor: 5.285

Review 6.  Lysosomal cathepsins and their regulation in aging and neurodegeneration.

Authors:  Veronika Stoka; Vito Turk; Boris Turk
Journal:  Ageing Res Rev       Date:  2016-04-26       Impact factor: 10.895

Review 7.  Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies.

Authors:  Adrien W Schmid; Bruno Fauvet; Marc Moniatte; Hilal A Lashuel
Journal:  Mol Cell Proteomics       Date:  2013-08-21       Impact factor: 5.911

8.  C-terminal truncation of α-synuclein promotes amyloid fibril amplification at physiological pH.

Authors:  Ingrid M van der Wateren; Tuomas P J Knowles; Alexander K Buell; Christopher M Dobson; Céline Galvagnion
Journal:  Chem Sci       Date:  2018-05-24       Impact factor: 9.825

9.  C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.

Authors:  Ryan P McGlinchey; Shannon M Lacy; Katherine E Huffer; Nahid Tayebi; Ellen Sidransky; Jennifer C Lee
Journal:  J Biol Chem       Date:  2019-05-15       Impact factor: 5.157

Review 10.  Cysteine cathepsins: from structure, function and regulation to new frontiers.

Authors:  Vito Turk; Veronika Stoka; Olga Vasiljeva; Miha Renko; Tao Sun; Boris Turk; Dušan Turk
Journal:  Biochim Biophys Acta       Date:  2011-10-12
View more
  4 in total

Review 1.  The Role of Extracellular Matrix Components in the Spreading of Pathological Protein Aggregates.

Authors:  Edoardo Moretto; Skye Stuart; Sunaina Surana; Jose Norberto S Vargas; Giampietro Schiavo
Journal:  Front Cell Neurosci       Date:  2022-04-29       Impact factor: 6.147

Review 2.  Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein Proteoforms.

Authors:  Norelle C Wildburger; Anna-Sophia Hartke; Alina Schidlitzki; Franziska Richter
Journal:  Front Cell Dev Biol       Date:  2020-11-17

3.  Targeted proteolytic products of τ and α-synuclein in neurodegeneration.

Authors:  Yuxing Xia; Grace M Lloyd; Benoit I Giasson
Journal:  Essays Biochem       Date:  2021-12-22       Impact factor: 8.000

4.  Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease.

Authors:  Ozge Karayel; Sebastian Virreira Winter; Shalini Padmanabhan; Yuliya I Kuras; Duc Tung Vu; Idil Tuncali; Kalpana Merchant; Anne-Marie Wills; Clemens R Scherzer; Matthias Mann
Journal:  Cell Rep Med       Date:  2022-06-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.